Lin H, Jeon A, Chen K, Lee C, Wu L, Chong S
Br J Cancer. 2025; .
PMID: 40057667
DOI: 10.1038/s41416-025-02969-8.
Choi D
Genomics Inform. 2025; 23(1):4.
PMID: 39934895
PMC: 11817428.
DOI: 10.1186/s44342-025-00038-3.
Akhlaq R, Ahmed T, Khan T, Yaseen Jeelani S, Joseph-Chowdhury J, Sidoli S
Epigenomics. 2024; 17(2):79-87.
PMID: 39716806
PMC: 11792842.
DOI: 10.1080/17501911.2024.2441652.
Lee P, Koseki L, Haitani T, Harada H, Kobayashi M
Cancers (Basel). 2024; 16(9).
PMID: 38730681
PMC: 11083728.
DOI: 10.3390/cancers16091729.
Yang F, Lee G, Fan Y
Angiogenesis. 2024; 27(3):333-349.
PMID: 38580870
PMC: 11303583.
DOI: 10.1007/s10456-024-09913-z.
Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator.
Karati D, Mukherjee S, Roy S
Med Oncol. 2024; 41(4):84.
PMID: 38438564
DOI: 10.1007/s12032-024-02303-x.
Nature's Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization.
Kumari R, Syeda S, Shrivastava A
Curr Med Chem. 2024; 31(32):5281-5304.
PMID: 38425113
DOI: 10.2174/0109298673282525240222050051.
Acetylation and Phosphorylation in the Regulation of Hypoxia-Inducible Factor Activities: Additional Options to Modulate Adaptations to Changes in Oxygen Levels.
Minisini M, Cricchi E, Brancolini C
Life (Basel). 2024; 14(1).
PMID: 38276269
PMC: 10821055.
DOI: 10.3390/life14010020.
Cancer epigenetics: from laboratory studies and clinical trials to precision medicine.
Yu X, Zhao H, Wang R, Chen Y, Ouyang X, Li W
Cell Death Discov. 2024; 10(1):28.
PMID: 38225241
PMC: 10789753.
DOI: 10.1038/s41420-024-01803-z.
[Chidamide inhibits proliferation and promotes apoptosis of esophageal squamous cell carcinoma cells by inhibiting the PI3K/Akt and ERK1/2 pathways and increasing DNA damage].
Gao M, Zhao B, Yang W, Tang J, Liu Y
Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(11):1926-1934.
PMID: 38081611
PMC: 10713458.
DOI: 10.12122/j.issn.1673-4254.2023.11.13.
Identification of angiogenesis-related genes signature for predicting survival and its regulatory network in glioblastoma.
Wan Z, Zuo X, Wang S, Zhou L, Wen X, Yao Y
Cancer Med. 2023; 12(16):17445-17467.
PMID: 37434432
PMC: 10501277.
DOI: 10.1002/cam4.6316.
Targeting histone deacetylases for cancer therapy: Trends and challenges.
Liang T, Wang F, Elhassan R, Cheng Y, Tang X, Chen W
Acta Pharm Sin B. 2023; 13(6):2425-2463.
PMID: 37425042
PMC: 10326266.
DOI: 10.1016/j.apsb.2023.02.007.
Intraoperative oxygen tension and redox homeostasis in Pseudomyxoma peritonei: A short case series.
Valenzuela-Molina F, Bura F, Vazquez-Borrego M, Granados-Rodriguez M, Rufian-Andujar B, Rufian-Pena S
Front Oncol. 2023; 13:1076500.
PMID: 36776312
PMC: 9909963.
DOI: 10.3389/fonc.2023.1076500.
Valproic acid and bladder healing: an experimental study in rats.
Biondo-Simoes M, Dallantonia M, Goehr M, Biondo-Simoes R, Ioshii S, Robes R
Rev Col Bras Cir. 2022; 49:e20223399.
PMID: 36449944
PMC: 10578821.
DOI: 10.1590/0100-6991e-20223399-en.
Cyclic enhancement of hypoxic microenvironment via an intelligent nanoamplifier for activated NIR-II fluorescence/photoacoustic imaging-guided precise synergistic therapy.
Zheng Z, Chen X, Dai R, Wu S, Kang W, Qin Y
Mater Today Bio. 2022; 17:100478.
PMID: 36388463
PMC: 9647404.
DOI: 10.1016/j.mtbio.2022.100478.
Epigenetic Regulation During Hypoxia and Its Implications in Cancer.
Pant D, Mutnuru S, Shukla S
Subcell Biochem. 2022; 100:361-390.
PMID: 36301500
DOI: 10.1007/978-3-031-07634-3_11.
RUNX Family in Hypoxic Microenvironment and Angiogenesis in Cancers.
Lee Y
Cells. 2022; 11(19).
PMID: 36231060
PMC: 9564080.
DOI: 10.3390/cells11193098.
Inhibition of Class I Histone Deacetylase Activity Blocks the Induction of TNFAIP3 Both Directly and Indirectly via the Suppression of Endogenous TNF-α.
Schioppa T, Nguyen H, Tiberio L, Sozio F, Gaudenzi C, Passari M
Int J Mol Sci. 2022; 23(17).
PMID: 36077149
PMC: 9456523.
DOI: 10.3390/ijms23179752.
Differential molecular mechanistic behavior of HDACs in cancer progression.
Singh T, Kaur P, Singh P, Singh S, Munshi A
Med Oncol. 2022; 39(11):171.
PMID: 35972597
DOI: 10.1007/s12032-022-01770-4.
The Role of HDACs in the Response of Cancer Cells to Cellular Stress and the Potential for Therapeutic Intervention.
Alseksek R, Ramadan W, Saleh E, El-Awady R
Int J Mol Sci. 2022; 23(15).
PMID: 35897717
PMC: 9331760.
DOI: 10.3390/ijms23158141.